Patrizia Passerini

A Randomized Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy

Claudio Ponticelli, P Zucchelli, Patrizia Passerini et al. · New England Journal of Medicine · 1989 · 231 citations

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

Francesco Scolari, Elisa Delbarba, Domenico Santoro et al. · Journal of the American Society of Nephrology · 2021 · 217 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

A Randomized Pilot Trial Comparing Methylprednisolone Plus a Cytotoxic Agent Versus Synthetic Adrenocorticotropic Hormone in Idiopathic Membranous Nephropathy

Claudio Ponticelli, Patrizia Passerini, Maurizio Salvadori et al. · American Journal of Kidney Diseases · 2006 · 181 citations

Glomerulonephritis, Renal Function, Idiopathic Membranous Nephropathy +6